These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 21214510)

  • 21. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights.
    Yoon H; Dehart JP; Murphy JM; Lim ST
    J Histochem Cytochem; 2015 Feb; 63(2):114-28. PubMed ID: 25380750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting FAK in anticancer combination therapies.
    Dawson JC; Serrels A; Stupack DG; Schlaepfer DD; Frame MC
    Nat Rev Cancer; 2021 May; 21(5):313-324. PubMed ID: 33731845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FAK inhibitors in cancer, a patent review - an update on progress.
    Ye YX; Cao YY; Xu LS; Wang HC; Liu XH; Zhu HL
    Expert Opin Ther Pat; 2024 Aug; 34(8):593-610. PubMed ID: 38946486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of focal adhesion kinase inhibitors in cancer therapy.
    Ma WW
    Anticancer Agents Med Chem; 2011 Sep; 11(7):638-42. PubMed ID: 21787276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
    Stone RL; Baggerly KA; Armaiz-Pena GN; Kang Y; Sanguino AM; Thanapprapasr D; Dalton HJ; Bottsford-Miller J; Zand B; Akbani R; Diao L; Nick AM; DeGeest K; Lopez-Berestein G; Coleman RL; Lutgendorf S; Sood AK
    Cancer Biol Ther; 2014 Jul; 15(7):919-29. PubMed ID: 24755674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.
    Stokes JB; Adair SJ; Slack-Davis JK; Walters DM; Tilghman RW; Hershey ED; Lowrey B; Thomas KS; Bouton AH; Hwang RF; Stelow EB; Parsons JT; Bauer TW
    Mol Cancer Ther; 2011 Nov; 10(11):2135-45. PubMed ID: 21903606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal adhesion kinase as a regulator of cell tension in the progression of cancer.
    Tilghman RW; Parsons JT
    Semin Cancer Biol; 2008 Feb; 18(1):45-52. PubMed ID: 17928235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase.
    Schultze A; Fiedler W
    Anticancer Agents Med Chem; 2011 Sep; 11(7):593-9. PubMed ID: 21787277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal adhesion kinase as a therapeutic target of bortezomib.
    Ko BS; Chang TC; Liou JY
    Anticancer Agents Med Chem; 2010 Dec; 10(10):747-52. PubMed ID: 21269258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal adhesion kinase inhibitors are potent anti-angiogenic agents.
    Cabrita MA; Jones LM; Quizi JL; Sabourin LA; McKay BC; Addison CL
    Mol Oncol; 2011 Dec; 5(6):517-26. PubMed ID: 22075057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances of Small Molecule Focal Adhesion Kinase (FAK) Inhibitors as Promising Anticancer Therapeutics.
    Lv P; Chen K; Zhu HL
    Curr Med Chem; 2021 Oct; 28(34):6977-6989. PubMed ID: 33797359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders.
    Wang X; Li N; Liu YH; Wu J; Liu QG; Niu JB; Xu Y; Huang CZ; Zhang SY; Song J
    Eur J Med Chem; 2024 Oct; 276():116678. PubMed ID: 39029337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of focal adhesion kinase in lung cancer.
    Dy GK
    Anticancer Agents Med Chem; 2013 May; 13(4):581-3. PubMed ID: 22934708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal adhesion kinase: a promising target for anticancer therapy.
    Chatzizacharias NA; Kouraklis GP; Theocharis SE
    Expert Opin Ther Targets; 2007 Oct; 11(10):1315-28. PubMed ID: 17907961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment.
    Roy-Luzarraga M; Hodivala-Dilke K
    Clin Cancer Res; 2016 Aug; 22(15):3718-24. PubMed ID: 27262114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal Adhesion Kinase as a Potential Target in AML and MDS.
    Carter BZ; Mak PY; Wang X; Yang H; Garcia-Manero G; Mak DH; Mu H; Ruvolo VR; Qiu Y; Coombes K; Zhang N; Ragon B; Weaver DT; Pachter JA; Kornblau S; Andreeff M
    Mol Cancer Ther; 2017 Jun; 16(6):1133-1144. PubMed ID: 28270436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial FAK as a therapeutic target in disease.
    Infusino GA; Jacobson JR
    Microvasc Res; 2012 Jan; 83(1):89-96. PubMed ID: 22008516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment.
    Wu X; Wang J; Liang Q; Tong R; Huang J; Yang X; Xu Y; Wang W; Sun M; Shi J
    Biomed Pharmacother; 2022 Jul; 151():113116. PubMed ID: 35598365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAK and interacting proteins as therapeutic targets in pancreatic cancer.
    Ucar DA; Hochwald SN
    Anticancer Agents Med Chem; 2010 Dec; 10(10):742-6. PubMed ID: 21235432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal adhesion kinase and p53 signal transduction pathways in cancer.
    Golubovskaya VM; Cance W
    Front Biosci (Landmark Ed); 2010 Jun; 15(3):901-12. PubMed ID: 20515733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.